𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Corrigendum to “Relationship of glutathine and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines”

✍ Scribed by Yellin, Seth A.; Davidson, Bruce J.; Pinto, John T.; Sacks, Peter G.; Qiao, Changhong; Schantz, Stimson P.

Book ID
122055256
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
61 KB
Volume
89
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Butyrate response factor 1 enhances cisp
Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines
✍ Seung Koo Lee; Seong Bum Kim; Jong Soo Kim; Chang Hoon Moon; Myung Shin Han; Byu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

Cisplatin is a widely used chemotherapeutic agent in head and neck squamous cell carcinoma (HNSCC). Resistance to cisplatin is a common feature of HNSCC. To identify genes that may regulate cisplatin sensitivity, we carried out a cDNA microarray analysis of gene expression in cisplatin-sensitive and

Glutathione-associated enzymes in head a
Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy
✍ Arnauld Cabelguenne; Marie-Anne Loriot; Isabelle Stucker; Hèléne Blons; Elisabet 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB

Glutathione S-transferases (GSTs) are metabolic phase II enzymes that promote reactive metabolite elimination by conjugating them to glutathione (GSH). Because of their important role in xenobiotic metabolism and detoxification, they have been implicated in carcinogenesis processes, especially epith

Hyperphosphorylation of replication prot
Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines
✍ Karoline C. Manthey; Jason G. Glanzer; Diana D. Dimitrova; Greg G. Oakley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 3 views

## Abstract ## Background Resistance to chemotherapy is a major limitation in the treatment of head and neck squamous cell carcinomas (HNSCCs), accounting for high mortality rates in patients. Here, we investigated the role of replication protein A (RPA) in cisplatin and etoposide resistance. ##